SavedAdd your journal

Journals / İstanbul Journal of Pharmacy / 2019 / Cilt: 49 - Sayı: 3

The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents

Zeliha PALA KARA
Büşra ÇAKIR
Deniz KALELİ DURMAN
B. Sönmez UYDEŞ DOĞAN
Pages
180–185
Publication Date
2019-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

DOI: 10.26650/IstanbulJPharm.2019.19042

🔖

Cite This Article

KARA, Z. P., ÇAKIR, B., DURMAN, D. K., DOĞAN, B. S. U. (2019). The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents. İstanbul Journal of Pharmacy, Cilt: 49 - Sayı: 3, 180–185. https://ajindex.com/articles/41749

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Aman MG, Farmer CA, Hollway J, Arnold LE. (2008) Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 17(4): 713–738.
  2. Baumer N, Spence SJ. (2018) Evaluation and Management of the Child With Autism Spectrum Disorder. Continuum (Minneap Minn) 24(1, Child Neurology):248-275.
  3. Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M, et al. (1994) A case-control family history study of autism. J Child Psychol Psychiatry 35(5): 877–900.
  4. Breik N, Kuo IF, Bugden S, Moffat M, Alessi-Severini S. (2018) Treating Children with ASD: The Perspective of Caregivers. J Pharm Pharm Sci 21(1):74-87.
  5. Cattane N, Richetto J, Cattaneo A. (2018) Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms. Neurosci Biobehav Rev 7634(17): 30972-7.
  6. Christensen D L, Baio J, Van Naarden BK, Bilder D, Charles J, Constantino J N, et al. (2016) Centers for Disease Control and Prevention Prevalence and characteristics of autismspectrumdisorder among children aged 8 years—Autismand Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveillance Summaries 65(3): 1–23.
  7. Davis TN, O-Reilly M, Kang S, et al. (2012) Chelation treatment for autism spectrum disorders: a systematic review. Res Autism Spectr Disord 7:49–55.
  8. DeFilippis M. (2018) The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder. Psychopharmacol Bull 48(1):40-63.
  9. DiGuiseppi C, Hepburn S, Davis JM, Fidler DJ, Hartway S, Lee N.R, et al. (2010) Screening for autism spectrum disorders in children with down syndrome. J Dev Behav Pediatr 31:181–191.
  10. Emberti Gialloreti L, Mazzone L, Benvenuto A, Fasano A, Alcon AG, Kraneveld A, et al.(2019) Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations. J Clin Med 8(2): 217-240.
  11. Goel R, Hong JS, Findling RL, Ji NY. (2018) An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Int Rev Psychiatry 30(1):78-95.
  12. Gyawali S and Patra BN.(2019) Autism spectrum disorder: Trends in research exploring etiopathogenesis. Psychiatry Clin Neurosci. Doi: 10.1111/pcn.12860. Hall SS, Lightbody AA, Reiss AL. (2008) Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard 113(1): 44–53